HealthVerity at ISPOR 2025: Solving RWD Challenges in Pharma and HEOR
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly changing the landscape of life sciences, offering powerful tools for streamlining clinical trials, optimizing drug development, and enhancing regulatory ...